JPRN-UMIN000003582已完成未知
The Observational Study of Chronic Myeloid Leukemia Patients in Chronic Phase with Resistance or Intolerance to Preceding TKI in Japan - The New Target Observational Study 2
The Japanese Society of Hematology0 个研究点目标入组 110 人开始时间: 2010年5月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients previously treated with any investigational drug for CML. 2)Women with confirmed or potential pregnancy, nursing mothers, and male or female patients who wish to have a child during the study period. 3)Patients with a history of allergy to imatinib, nilotinib or dasatinib. 4)Patients with any concomitant illness that contraindicates use of imatinib, nilotinib or dasatinib. 5)Patients with any other condition that, in the investigator's opinion, disqualifies them for inclusion in the study.
研究者
相似试验
已完成
不适用
The Observational Study of De Novo Chronic Myeloid Leukemia Patients in Chronic Phase in JapaChronic Myeloid LeukemiaJPRN-UMIN000003581The Japanese Society of Hematology500
尚未招募
不适用
Chronic Myeloid LeukemiaCTRI/2021/08/035398DRREETIKA RAMANATHA
已完成
不适用
CML V - chronic phase Chronic Myeloid LeukaemiaeukaemiaMyeloid leukaemiaCancerISRCTN68784584niversity of Oxford (UK)800
已完成
不适用
CML IV - Chronic phase chronic myeloid leukaemia/CML 2000eukaemiaChronic myeloid leukaemiaCancerISRCTN61147621Medical Research Council (MRC) (UK)800
已完成
不适用
Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent LineChronic Myeloid LeukemiaNCT05734053Novartis Pharmaceuticals222